Epygen Biotech
PrivateLast Round
Grant
Apr 11, 2022
Total Funding Raised
$3.16M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Epygen Biotech operates in Healthcare & Life Sciences and is based in Dubai. Its latest recorded funding round was a Grant round in April 2022.
Epygen Biotech is a biotechnology company that specializes in the research and manufacturing of therapeutic proteins for oncology, cardiovascular, and immune disorders, as well as vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epygen Biotech Comparables
Compare Epygen Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dyadic International Inc | 72% | |
| Creative Enzymes | 72% | |
| Enzymaster | 68% |
For institutional investors. Book with your work email.
Epygen Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 11, 2022 | ||||
| Early Funding | May 10, 2018 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 1856% MoM, reaching 6.7K.
- Jan 20, 2026
Monthly visitors increased 713% MoM.
For institutional investors. Book with your work email.
Epygen Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epygen Biotech's valuation, stock price, and market status.
Is Epygen Biotech a public or private company?
Epygen Biotech is a private company.
What is the current stock price of Epygen Biotech?
Epygen Biotech is a private company, so its shares have no public market price. Caplight tracks Epygen Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epygen Biotech worth (valuation)?
Valuation information for Epygen Biotech is not publicly available.
Can I buy Epygen Biotech stock?
Epygen Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epygen Biotech's last funding round?
Epygen Biotech's most recent funding round was Grant on April 11, 2022.
Who are the main investors in Epygen Biotech?
Investor information for Epygen Biotech is not publicly disclosed.
Will Epygen Biotech IPO soon?
No public IPO plans have been announced for Epygen Biotech.
How can I track Epygen Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Epygen Biotech's shares on secondary markets.